OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
St. Luke’s Children’s Hospital
May 03, 2021
Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.
April 26, 2021
A discussion on ease of access for dupilumab for the treatment of atopic dermatitis including the process for approval and coverage.
Examining the potential role for biologic, dupilumab, in the treatment of moderate to severe atopic dermatitis.
April 19, 2021
A review of the safety and efficacy of systemic agents such as methotrexate, azathioprine, and cyclosporine in patients with severe, persistent atopic dermatitis.